Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

Tissue Antigens

Volumn 47, Issue 5, 1996, Pages 372-381

  Torres, M J ^a   Ruiz Cabello, F ^a   Skoudy, A ^b   Berrozpe, G ^b   Jimenez, P ^a   Serrano, A ^a   Real, F X ^b   Garrido, F ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

IEF (isoelectric focusing); LOH (loss of heterozygosity); mAB; MHC (major histocompatibility complex); Monoclonal antibody; 2 m; 2 microglobulin

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN;

ALLELE; ARTICLE; CHROMOSOME 6; HAPLOTYPE; HETEROZYGOSITY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOELECTRIC FOCUSING; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE; PANCREAS CANCER; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; TUMOR CELL LINE;

EID: 0029936243     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02572.x     Document Type: Article

References (43)

1. Garrido F, Cabrera T, Concha A et al. Natural history of HLA expression during tumor development. Immunol Today 1993: 14: 491-499.
2. Ruiz Cabello F, Klein E Garrido F. MHC antigens on human tumors. Immunol Lett 1991a: 29: 181-189.
3. Garrido F, Ruiz Cabello F. MHC expression on human tumors-its relevance for local tumor growth and metastasis. Semin Cancer Biol 1991: 2: 3-10.
4. Momburg F, Ziegler A, Harpprecht J et al. Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. J Immunol 1989: 142: 352-358.
5. Lopez Nevot MA, Esteban F, Ferron A et al. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br J Cancer 1989: 59: 221-226.
6. Andersson ML, Stam NJ, Klein G et al. Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells. Int J Cancer 1991: 47: 544-550.
7. Mukherji B, Guha A, Chakraborty NG et al. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J Exp Med 1989: 169: 1961-1976.
8. Versteeg R, Peltenburg LTC, Plomp AC et al. High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells. J Immunol 1989: 143: 4331-4337.
9. Redondo M, Ruiz Cabello F, Concha A et al. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation. Cancer Res 1991: 51: 2463-2468.
10. Blanchet O, Bourge JF, Zinszer H et al. DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC class I transcriptional level in class I defective cell lines. Intl J Cancer 1991: 6(suppl): 138-145.
11. Soong TW, Hui KM Locus-specific transcriptional control of HLA genes. J Immunol 1992: 149: 2008-2020.
12. Restifo NP, Esquivel F, Kawakami Y et al. Identification of human cancers deficient in antigen processing. J Exp Med 1993: 177: 265-272.
13. 2m gene expression. J Clin Invest 1991: 87: 284-292
14. van't Veer LJ, Beijersbergen RL Bernards R. N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of. EMBO J 1993: 12: 195-200.
15. Warshaw AL, Fernandez del Castillo C. Pancreatic carcinoma. N Engl J Med 1992: 326: 455-465.
16. Vilá MR, Lloreta J, Schüssler MH et al. New pancreas cancer cell lines which represent distinct stages of ductal differentiation. Lab Invest (in press).
17. Cubilla AL, Fitzgerald PJ. Surgical pathology of tumors of exocrine pancreas. In: Mossa AR, Wilkins W, ed. Tumors of the pancreas. Baltimore: Williams and Wilkins, 1990.
18. Barnstable CJ, Bodmer WF, Brown G et al. Production of monoclonal antibodies to group A erythrocytes, HLA, and other human cell surface antigens. New tools for genetic-analysis. Cell 1978: 14: 9-20.
19. Stam NJ, Spits H Ploegh HL. Monoclonal antibodies raised against denatured HLA B locus heavy chains permit biochemical characterization of certain HLA C locus products. J Immunol 1986: 137: 2299-2306.
20. Lopez-Nevot MA, Cabrera MT, De la Higuera B et al. Production and characterization of monoclonal antibodies against leukemic cells. Inmunologia 1986: 5: 51-59.
21. 1 domain of HLA A molecules. Immunogenetics 1989: 30: 50-53.
22. Lozano F, Borche L, Places L et al. Biochemical and serological characterization of a public antigenic determinate present on HLA B molecules. Tissue Antigens 1990: 35: 193-200.
23. Yang SY, Morishima Y, Collins NH et al. Comparison of one dimensional IEF patterns for serologically detectable HLA A and B allotypes. Immunogenetics 1984: 19: 217-232.
24. Schüssler MH, Skoudy A, Ramaekers FCS et al. Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol 1992: 140: 559-568.
25. Cordell JL, Falini B, Erber WN et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphalase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem 1984: 32: 219-229.
26. Ruiz Cabello F, Perez Ayala M, Gomez O et al. Molecular analysis of MHC-class-I alterations in human tumor cell lines. Int J Cancer 1991: 6(suppl): 123-130.
27. Watkins DI, Kannagi M, Stone ME et al. Major histocompatibility complex class I molecules of non-human primates. Eur J Immunol 1988: 18: 1425-1432.
28. Albert E, Sierpe E, Keller E et al. Oligotyping with DRB generic amplified DNA and oligonucleotides 0-25. In: Tsuji M, Aizawa M, Sazazuki T, ed. Proceedings of the Eleventh International Histocompatibility Workshop and Conference, Oxford: Oxford University Press, 1991: 454-456.
29. Weber JL, Kwitek A, May PE. Dinucleotide repeat polymorphism at the D6S87 locus. Nucleic Acids Res 1990: 18: 4636.
30. Gyapay G, Morisette J, Vignal A et al. The 1993-1994 Genethon human genetic maps. Nature Genet 1994: 7: 246-249.
31. Houghton AN, Thomson TM, Gross D et al. Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon. J Exp Med 1984: 160: 255-269.
32. Möller P, Hammerling P. The role of surface HLA-A,B,C molecules in tumor immunity. Cancer Surv 1992: 13: 101-128.
33. Kaklamanis L, Hill A. MHC loss in colorectal tumours: evidence for immunoselection? Cancer Surv 1992: 13: 155-172.
34. Martinez-Laso J, Bemmar D, Alvarez M et al. Frecuencias alélicas y haplotípicas HLA en argelinos: relacion con los españoles y vascos. Inmunología 1995: 14: 57.
35. Solomon E, Voss R, Hall V et al. Chromosome 5 allele loss in human colorectal carcinomas. Nature (London) 1987: 328: 616-619.
36. Browning MJ, Krausa P, Rowan A et al. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci U S A 1993: 90: 2842-2845.
37. Marincola FM, Shamamian P, Alexander RB et al. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J Immunol 1994: 153: 1225-1237.
38. Seung S, Urban JL, Schreiber H. A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target. J Exp Med 1993: 178: 933-940.
39. Rodriguez E, Sreekantaiah C, Chaganti RS. Genetic changes in epithelial solid neoplasia. Cancer Res 1994: 54: 3398-3406.
40. Ding SF, Habib NA, Delhanty JD et al. Loss of heterozygosity on chromosomes 1 and 11 in carcinoma of the pancreas. Br J Cancer 1992: 65: 809-812.
41. Seymour AB, Hruban RH, Redston M et al. Allelotype of pancreatic adenocarcinoma. Cancer Res 1994: 54: 2761-2764.
42. Griffin CA, Hruban RH, Long PP et al. Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosom Cancer 1994: 9: 93-100.
43. el Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993: 75: 817-825.